New Cervical Cancer Test Saves Women from Unnecessary Procedures

Nov. 25, 2015
Cancer Genetics' (NASDAQ: CGIX) FHACT cervical cancer screening test saves women from unnecessary and costly procedures. Learn more at: ...

 Read More

"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President, NASDAQ Stock Market